Clinical trial

ATLG Levels in Autologous HSCT for Multiple Sclerosis

NCT07635693

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2026-05-04

PhaseN/A

Study timeline

Study start (actual)2026-05-04Date precision: day

Registry last updated2026-06-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Autologous Hematopoietic Stem Cell Transplantunresolved

ATLGunresolved

Interventions

ATLG administrationDRUG

Sponsors & collaborators

Ciceri Fabiolead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07635693 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.